Study on Xeloda to Document Its Use in Routine Practice in Patients With Metastatic or Advanced Breast Cancer
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Capecitabine (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms XEPAD
- Sponsors Roche
- 23 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2014 Planned End Date changed from 1 Oct 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 08 Dec 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Mar 2015 as reported by ClinicalTrials.gov.